Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse P Cadherin ELISA Kit (AC3267)
Cat.#: ASET-1856
Specifications
Description Mouse P Cadherin ELISA Kit allows for the in vitro quantitative determination of mouse P Cadherin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1277 Rat BACE2 ELISA Kit (AC2688) Quantitative inquiry ASET-1901 Mouse CRMP2 ELISA Kit (AC3312) Quantitative inquiry ASET-1807 Human Synaptotagmin VII ELISA Kit (AC3218) Quantitative inquiry ASET-2474 Human NOTUM ELISA Kit (AC3885) Quantitative inquiry ASET-2109 Rat beta 1 Adrenergic Receptor ELISA Kit (AC3520) Quantitative inquiry ASET-2246 Human NT-4 ELISA Kit (AC3657) Quantitative inquiry ASET-2140 Rat Laminin ELISA Kit (AC3551) Quantitative inquiry ASET-2439 Human PON3 ELISA Kit (AC3850) Quantitative inquiry ASET-1633 Monkey GAP43 ELISA Kit (AC3044) Quantitative inquiry ASET-1719 Porcine Adiponectin ELISA Kit (AC3130) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket